Altman Biomedical Consulting Pty. Ltd. Report issue

For profit Phase 4
Founded: Cammeray Australia (2006)
Status: No NME R&D (2006)

Organization Overview

First Clinical Trial
2009
NCT00995124
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

eucalyptus oil (1 trial)

lavender (1 trial)

tea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lice Infestations (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3